Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Rasagiline Mesylate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel chiral auxiliary method for rasagiline production offering high yield and reduced pollution for pharmaceutical manufacturers seeking reliable supply chains.
Patent CN101062897B details a novel Al-Ni alloy reduction for 2,3-dihydro-1H-inden-1-amine. This report analyzes cost reduction in API manufacturing and supply chain reliability.
Novel trifluoroacetyl protection route for high-purity rasagiline. Reduces waste, avoids resolution, ensures supply continuity for Parkinson's API manufacturing.
Novel chiral synthesis of Rasagiline Mesylate from 1-indanone. High yield, low cost, industrial scale-up ready for Parkinson's API intermediates.